全部股東
股東類型
- 公眾及其他65.20%
- 機構投資者12.19%
- 創投/私募10.19%
- 對沖基金7.82%
- 其他4.61%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Khosla Ventures, LLC | 10.19% | 263.22 萬 | -- | +263.22 萬 | 15/06/2026 |
Montanova Capital, LLC | 7.82% | 202.01 萬 | 5.24% | +198.56 萬 | 15/06/2026 |
Anand ParikhCEO, President & Chair | 3.16% | 81.77 萬 | 3.16% | +81.77 萬 | 22/06/2026 |
Vivo Capital, LLC | 2.79% | 72.20 萬 | -- | +72.20 萬 | 31/03/2026 |
Franklin Resources, Inc. | 1.91% | 49.45 萬 | 8.05% | +36.10 萬 | 30/06/2026 |
Cormorant Asset Management, LP | 1.19% | 30.62 萬 | -- | +30.62 萬 | 31/03/2026 |
H&S Ventures LLC | 0.86% | 22.21 萬 | 16.68% | +781.00 | 31/03/2026 |
Marshall Wace LLP | 0.80% | 20.65 萬 | 4.10% | +14.08 萬 | 30/06/2026 |
Patient Square Capital, LP | 0.68% | 17.51 萬 | -- | +17.51 萬 | 30/06/2026 |
Affinity Asset Advisors, LLC | 0.56% | 14.44 萬 | -- | +14.44 萬 | 30/06/2026 |
StemPoint Capital LP | 0.51% | 13.29 萬 | -- | +13.29 萬 | 31/03/2026 |
James PeyerFormer Independent Director | 0.50% | 13.01 萬 | -- | +13.01 萬 | |
Cambrian BioPharma, Inc. | 0.50% | 13.01 萬 | 11.07% | -2.50 萬 | |
Caligan Partners, LP | 0.49% | 12.60 萬 | -- | +12.60 萬 | 31/03/2026 |
Trails Edge Capital Partners, LP | 0.48% | 12.50 萬 | -- | +12.50 萬 | 31/03/2026 |
Richmond Investment Services, LLC | 0.31% | 7.97 萬 | -- | +7.97 萬 | 30/06/2026 |
The Goldman Sachs Group, Inc. | 0.24% | 6.16 萬 | 4.36% | +0 | 30/06/2026 |
Hudson River Trading LLC | 0.22% | 5.80 萬 | -- | +5.80 萬 | 31/03/2026 |
Brian StephensonChief Financial Officer | 0.18% | 4.67 萬 | -- | +4.67 萬 | |
Stephen HahnDirector | 0.17% | 4.48 萬 | -- | +4.48 萬 | 15/06/2026 |